Liver hepatotoxicity associated with pantoprazole: a rare case report

Wien Klin Wochenschr. 2014 Jun;126(11-12):390-2. doi: 10.1007/s00508-014-0535-3. Epub 2014 Mar 21.

Abstract

Hepatotoxicity may occasionally develop over the course of treatment with proton pump inhibitors (PPIs). Although skin reactions, interstitial nephritis, pancytopenia, anaphylaxis, and generalized edema have been reported to be associated with PPIs, hepatotoxicity associated with oral pantoprazole is very rare. In this report, we present a case of hepatotoxicity in a 35-year-old man who received pantoprazole (40 mg/day) for acute gastritis. One week after discontinuation of pantoprazole, his liver function began to improve, and the patient gradually fully recovered. Although this toxicity occurs only infrequently, pantoprazole should be considered as a rare hepatotoxic agent in the literature.

Publication types

  • Case Reports

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / adverse effects*
  • Abdominal Pain / chemically induced*
  • Abdominal Pain / diagnosis*
  • Abdominal Pain / prevention & control
  • Anti-Ulcer Agents / adverse effects
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / prevention & control
  • Diagnosis, Differential
  • Humans
  • Male
  • Pantoprazole
  • Proton Pump Inhibitors / adverse effects
  • Rare Diseases / chemically induced
  • Rare Diseases / diagnosis
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Proton Pump Inhibitors
  • Pantoprazole